US Stock MarketDetailed Quotes

PYXS Pyxis Oncology

Watchlist
  • 1.900
  • -0.200-9.52%
Close Nov 22 16:00 ET
  • 1.930
  • +0.030+1.58%
Pre 09:18 ET
112.98MMarket Cap-1792P/E (TTM)

Pyxis Oncology Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
16.15M
0
0
0
0
0
0
0
Operating revenue
--0
--0
--16.15M
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
0
0
475K
0
0
0
Gross profit
0
0
15.67M
0
0
0
Operating expense
-6.31%23.75M
10.55%20.03M
1.54%21.28M
-33.43%82.2M
-53.21%17.77M
-10.70%25.35M
-29.56%18.12M
-33.24%20.95M
77.12%123.48M
131.18%37.97M
Selling and administrative expenses
-43.63%6.01M
-9.67%6.08M
-8.90%8.25M
-12.70%32.61M
-24.13%6.16M
13.98%10.67M
-21.34%6.73M
-20.01%9.05M
100.14%37.35M
-11.75%8.12M
-General and administrative expense
-43.63%6.01M
-9.67%6.08M
-8.90%8.25M
-12.70%32.61M
-24.13%6.16M
13.98%10.67M
-21.34%6.73M
-20.01%9.05M
100.14%37.35M
-11.75%8.12M
Research and development costs
20.79%17.74M
22.49%13.95M
9.48%13.03M
-42.43%49.59M
-61.12%11.61M
-22.84%14.69M
-33.66%11.39M
-40.71%11.9M
68.70%86.13M
313.15%29.85M
Operating profit
6.31%-23.75M
-10.55%-20.03M
73.25%-5.61M
33.43%-82.2M
53.21%-17.77M
10.70%-25.35M
29.56%-18.12M
33.24%-20.95M
-77.12%-123.48M
-131.18%-37.97M
Net non-operating interest income expense
8.14%1.85M
22.16%2.02M
-7.35%1.55M
139.87%6.63M
-14.85%1.59M
137.41%1.71M
909.76%1.66M
18,488.89%1.67M
11,917.39%2.76M
26,642.86%1.87M
Non-operating interest income
8.14%1.85M
22.16%2.02M
-7.35%1.55M
139.87%6.63M
-14.85%1.59M
137.41%1.71M
909.76%1.66M
18,488.89%1.67M
11,917.39%2.76M
26,642.86%1.87M
Other net income (expense)
17.89%705K
25.53%708K
2,002.63%799K
1.78M
576K
598K
564K
38K
Other non- operating income (expenses)
17.89%705K
25.53%708K
2,002.63%799K
--1.78M
--576K
--598K
--564K
--38K
----
----
Income before tax
8.01%-21.2M
-8.80%-17.3M
83.08%-3.26M
38.87%-73.79M
56.80%-15.6M
16.71%-23.05M
37.79%-15.9M
38.68%-19.24M
-58.89%-120.72M
-114.52%-36.1M
Income tax
Net income
8.01%-21.2M
-8.80%-17.3M
83.08%-3.26M
38.87%-73.79M
56.80%-15.6M
16.71%-23.05M
37.79%-15.9M
38.68%-19.24M
-58.89%-120.72M
-114.52%-36.1M
Net income continuous Operations
8.01%-21.2M
-8.80%-17.3M
83.08%-3.26M
38.87%-73.79M
56.80%-15.6M
16.71%-23.05M
37.79%-15.9M
38.68%-19.24M
-58.89%-120.72M
-114.52%-36.1M
Minority interest income
Net income attributable to the parent company
8.01%-21.2M
-8.80%-17.3M
83.08%-3.26M
38.87%-73.79M
56.80%-15.6M
16.71%-23.05M
37.79%-15.9M
38.68%-19.24M
-58.89%-120.72M
-114.52%-36.1M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
8.01%-21.2M
-8.80%-17.3M
83.08%-3.26M
38.87%-73.79M
56.80%-15.6M
16.71%-23.05M
37.79%-15.9M
38.68%-19.24M
-58.89%-120.72M
-114.52%-36.1M
Basic earnings per share
37.50%-0.35
29.27%-0.29
88.89%-0.06
49.32%-1.85
68.27%-0.33
34.12%-0.56
48.10%-0.41
44.33%-0.54
59.22%-3.65
-99.13%-1.04
Diluted earnings per share
37.50%-0.35
29.27%-0.29
88.89%-0.06
49.32%-1.85
68.27%-0.33
34.12%-0.56
48.10%-0.41
44.33%-0.54
59.22%-3.65
-99.13%-1.04
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 0016.15M0000000
Operating revenue --0--0--16.15M--0--0--0--0--0--0--0
Cost of revenue 00475K000
Gross profit 0015.67M000
Operating expense -6.31%23.75M10.55%20.03M1.54%21.28M-33.43%82.2M-53.21%17.77M-10.70%25.35M-29.56%18.12M-33.24%20.95M77.12%123.48M131.18%37.97M
Selling and administrative expenses -43.63%6.01M-9.67%6.08M-8.90%8.25M-12.70%32.61M-24.13%6.16M13.98%10.67M-21.34%6.73M-20.01%9.05M100.14%37.35M-11.75%8.12M
-General and administrative expense -43.63%6.01M-9.67%6.08M-8.90%8.25M-12.70%32.61M-24.13%6.16M13.98%10.67M-21.34%6.73M-20.01%9.05M100.14%37.35M-11.75%8.12M
Research and development costs 20.79%17.74M22.49%13.95M9.48%13.03M-42.43%49.59M-61.12%11.61M-22.84%14.69M-33.66%11.39M-40.71%11.9M68.70%86.13M313.15%29.85M
Operating profit 6.31%-23.75M-10.55%-20.03M73.25%-5.61M33.43%-82.2M53.21%-17.77M10.70%-25.35M29.56%-18.12M33.24%-20.95M-77.12%-123.48M-131.18%-37.97M
Net non-operating interest income expense 8.14%1.85M22.16%2.02M-7.35%1.55M139.87%6.63M-14.85%1.59M137.41%1.71M909.76%1.66M18,488.89%1.67M11,917.39%2.76M26,642.86%1.87M
Non-operating interest income 8.14%1.85M22.16%2.02M-7.35%1.55M139.87%6.63M-14.85%1.59M137.41%1.71M909.76%1.66M18,488.89%1.67M11,917.39%2.76M26,642.86%1.87M
Other net income (expense) 17.89%705K25.53%708K2,002.63%799K1.78M576K598K564K38K
Other non- operating income (expenses) 17.89%705K25.53%708K2,002.63%799K--1.78M--576K--598K--564K--38K--------
Income before tax 8.01%-21.2M-8.80%-17.3M83.08%-3.26M38.87%-73.79M56.80%-15.6M16.71%-23.05M37.79%-15.9M38.68%-19.24M-58.89%-120.72M-114.52%-36.1M
Income tax
Net income 8.01%-21.2M-8.80%-17.3M83.08%-3.26M38.87%-73.79M56.80%-15.6M16.71%-23.05M37.79%-15.9M38.68%-19.24M-58.89%-120.72M-114.52%-36.1M
Net income continuous Operations 8.01%-21.2M-8.80%-17.3M83.08%-3.26M38.87%-73.79M56.80%-15.6M16.71%-23.05M37.79%-15.9M38.68%-19.24M-58.89%-120.72M-114.52%-36.1M
Minority interest income
Net income attributable to the parent company 8.01%-21.2M-8.80%-17.3M83.08%-3.26M38.87%-73.79M56.80%-15.6M16.71%-23.05M37.79%-15.9M38.68%-19.24M-58.89%-120.72M-114.52%-36.1M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 8.01%-21.2M-8.80%-17.3M83.08%-3.26M38.87%-73.79M56.80%-15.6M16.71%-23.05M37.79%-15.9M38.68%-19.24M-58.89%-120.72M-114.52%-36.1M
Basic earnings per share 37.50%-0.3529.27%-0.2988.89%-0.0649.32%-1.8568.27%-0.3334.12%-0.5648.10%-0.4144.33%-0.5459.22%-3.65-99.13%-1.04
Diluted earnings per share 37.50%-0.3529.27%-0.2988.89%-0.0649.32%-1.8568.27%-0.3334.12%-0.5648.10%-0.4144.33%-0.5459.22%-3.65-99.13%-1.04
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data